Literature DB >> 11682665

Cellular interleukin-1 receptor antagonist production in patients receiving on-line haemodiafiltration therapy.

B Canaud1, V Wizemann, F Pizzarelli, R Greenwood, G Schultze, C Weber, D Falkenhagen.   

Abstract

BACKGROUND: Repetitive exposure to cytokine-inducing substances (pyrogens) results in chronic inflammation, which may significantly contribute to some of the long-term complications in dialysis patients. On-line dialysis modalities, such as on-line haemodiafiltration (HDF), raise particular concerns because of the administration of infusate prepared from potentially contaminated dialysis fluid. Hence, great retention capability for pyrogens is of critical importance for the safe performance of on-line systems.
METHODS: The microbiological safety of a novel on-line system, ONLINEplus(TM), was assessed in clinical practice in five centres for 3 months. Infusate and dialysis fluid were regularly monitored for microbial counts, endotoxins, and cytokine-inducing activity. Levels of interleukin-1 receptor antagonist (IL-1Ra) were determined in supernatants of whole blood incubated either under pyrogen-free conditions (spontaneous cytokine production) or following low-dose endotoxin exposure (LPS-stimulated cytokine production).
RESULTS: We failed to detect microorganisms or endotoxin contamination of infusate during the entire study period. Moreover, neither infusate nor dialysis fluid demonstrated cytokine-inducing activity. Intradialytic IL-1Ra induction was not detected, as there was no difference between pre- and post-session values for both spontaneous and LPS-stimulated IL-1Ra production (115+/-26 vs 119+/-27 and 2445+/-353 vs 2724+/-362 pg/10(6) white blood cells (WBC), respectively). Neither the number of immunocompetent cells nor their capacity to produce IL-1Ra declined during this period, indicating that cells were not significantly stimulated during treatment. Spontaneous and LPS-induced exvivo IL-1Ra generation remained unchanged after 3 months of on-line HDF therapy as compared with the start of the study (71+/-30 pre- vs 48+/-14 post-study, and 2559+/-811 vs 2384+/-744 pg/10(6) WBC, respectively).
CONCLUSIONS: The present on-line system performed safely from a microbiological view-point as both the dialysis fluid and infusate were consistently free of microorganisms, endotoxins, and cytokine-inducing substances. As a result, on-line HDF therapy had no effect upon the chronic inflammatory responses in end-stage renal disease patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11682665     DOI: 10.1093/ndt/16.11.2181

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  5 in total

1.  Hemodiafiltration beneficially affects QT interval duration and dispersion compared to hemodialysis.

Authors:  Kitti Barta; Árpád Czifra; Csaba Kun; Alida Páll; Julianna Kulcsár; György Paragh; István Lőrincz; Tamás János Padra; Anupam Agarwal; Abolfazl Zarjou; Zarjou Abolfazl; József Balla; Zoltán Szabó
Journal:  Clin Exp Nephrol       Date:  2014-03-04       Impact factor: 2.801

2.  Citrate high volume on-line hemodiafiltration modulates serum Interleukin-6 and Klotho levels: the multicenter randomized controlled study "Hephaestus".

Authors:  Francesco Pizzarelli; Vincenzo Cantaluppi; Vincenzo Panichi; Alessandro Toccafondi; Giuseppe Ferro; Serena Farruggio; Elena Grossini; Pietro Claudio Dattolo; Vincenzo Miniello; Massimiliano Migliori; Cristina Grimaldi; Aldo Casani; Maurizio Borzumati; Stefano Cusinato; Alessandro Capitanini; Alessandro Quercia; Oliviero Filiberti; Lucia Dani
Journal:  J Nephrol       Date:  2021-02-09       Impact factor: 3.902

3.  Treatment of hepatic encephalopathy by on-line hemodiafiltration: a case series study.

Authors:  Shinju Arata; Katsuaki Tanaka; Kazuhisa Takayama; Yoshihiro Moriwaki; Noriyuki Suzuki; Mitsugi Sugiyama; Kazuo Aoyagi
Journal:  BMC Emerg Med       Date:  2010-05-21

4.  Hemodialysis and hemodiafiltration differently modulate left ventricular diastolic function.

Authors:  Arpád Czifra; Alida Páll; Julianna Kulcsár; Kitti Barta; Attila Kertész; György Paragh; István Lőrincz; Zoltán Jenei; Anupam Agarwal; Abolfazl Zarjou; József Balla; Zoltán Szabó
Journal:  BMC Nephrol       Date:  2013-04-02       Impact factor: 2.388

5.  Post-dilution on line haemodiafiltration with citrate dialysate: first clinical experience in chronic dialysis patients.

Authors:  Vincenzo Panichi; Enrico Fiaccadori; Alberto Rosati; Roberto Fanelli; Giada Bernabini; Alessia Scatena; Francesco Pizzarelli
Journal:  ScientificWorldJournal       Date:  2013-12-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.